Insights
Showing 13 - 24 of 36 results
As Oct. 1 nears, so does the threat of strikes for U.S. East Coast and Gulf Coast ports. Here’s what you can do to prepare... read more
Cellular and gene therapy — a rapidly growing field that involves modifying gene expression or cell properties for therapeutic purposes... read more
As inpatient and outpatient volumes grow over the next decade, health systems must optimize care delivery for their increasingly aging complex patients. Vizient experts discuss how the 2024 Impact of... read more
While the supply chain may feel complex, the good news is that there are still methods — like Drug Shortage Stewardship — that can be implemented to mitigate drug shortages... read more
Drug shortages and their management have become a major focus of pharmacy staff within hospitals and health systems, which is why maintaining an institution-specific drug shortage list may be critica... read more
With the increasing shift of treatment from inpatient to outpatient settings, come questions about which medications can safely be used at alternate sites of care facilities. The new Vizient Pharmacy... read more
Specialty pharmaceuticals have exploded into the modern healthcare scene, and with one-third of growth stemming from hospital or health system-owned specialty pharmacies, awareness of specialty drug ... read more
Between news headlines and social media influencers raving about their weight loss, it appears semaglutide may be the miracle weight loss drug the world’s been waiting for. But should the healthcare ... read more
The challenges around hiring and retaining quality pharmacy technicians in the workforce today is a fast-growing issue. And the solution is clear... read more
Given the incredible amounts of time and money invested in the specialty pharmacy market, it is important for key stakeholders to understand what medications are classified as specialty... read more
Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discu... read more
The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers... read more